Impediments to Implementing Guideline-Directed Medical Therapies

Gregg C. Fonarow; Ann Marie Navar; Clyde W. Yancy

doi:10.1001/jamacardio.2019.2276

Impediments to Implementing Guideline-Directed Medical Therapies

Gregg C. Fonarow^*, Ann Marie Navar, Clyde W. Yancy

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	830-831
Number of pages	2
Journal	JAMA cardiology
Volume	4
Issue number	8
DOIs	https://doi.org/10.1001/jamacardio.2019.2276
State	Published - Aug 2019

Funding

reports research funding from the National Institutes of Health and personal fees from Abbott, Amgen, Bayer, Janssen, Medtronic, and Novartis, outside the submitted work. Dr Navar reports grants and personal fees from Amarin, Amgen, Regeneron, and Sanofi; personal fees from Novo Nordisk and AstraZeneca; and grants from Janssen, outside the submitted work. Dr Yancy reports spousal employment with Abbott Inc. No other disclosures were reported.

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1001/jamacardio.2019.2276

Cite this

@article{625dd4fad9ea43039163a9c9fe3e9a1a,

title = "Impediments to Implementing Guideline-Directed Medical Therapies",

author = "Fonarow, {Gregg C.} and Navar, {Ann Marie} and Yancy, {Clyde W.}",

note = "Funding Information: reports research funding from the National Institutes of Health and personal fees from Abbott, Amgen, Bayer, Janssen, Medtronic, and Novartis, outside the submitted work. Dr Navar reports grants and personal fees from Amarin, Amgen, Regeneron, and Sanofi; personal fees from Novo Nordisk and AstraZeneca; and grants from Janssen, outside the submitted work. Dr Yancy reports spousal employment with Abbott Inc. No other disclosures were reported.",

year = "2019",

month = aug,

doi = "10.1001/jamacardio.2019.2276",

language = "English (US)",

volume = "4",

pages = "830--831",

journal = "JAMA cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - Impediments to Implementing Guideline-Directed Medical Therapies

AU - Fonarow, Gregg C.

AU - Navar, Ann Marie

AU - Yancy, Clyde W.

N1 - Funding Information: reports research funding from the National Institutes of Health and personal fees from Abbott, Amgen, Bayer, Janssen, Medtronic, and Novartis, outside the submitted work. Dr Navar reports grants and personal fees from Amarin, Amgen, Regeneron, and Sanofi; personal fees from Novo Nordisk and AstraZeneca; and grants from Janssen, outside the submitted work. Dr Yancy reports spousal employment with Abbott Inc. No other disclosures were reported.

PY - 2019/8

Y1 - 2019/8

UR - http://www.scopus.com/inward/record.url?scp=85068888763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068888763&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2019.2276

DO - 10.1001/jamacardio.2019.2276

M3 - Letter

C2 - 31290930

AN - SCOPUS:85068888763

SN - 2380-6583

VL - 4

SP - 830

EP - 831

JO - JAMA cardiology

JF - JAMA cardiology

IS - 8

ER -

Impediments to Implementing Guideline-Directed Medical Therapies

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this